Ketanserin (Sigma), an antagonist for 5HTR2A, was dissolved in 0.1 M HCl, diluted with PBS, and administered in a dosing volume of 0.1 mg/mouse. SB-204741 (Tocris Bioscience, Bristol, UK), an antagonist for 5HTR2B, was dissolved in DMSO, diluted with PBS such that the final concentration of DMSO was 0.1%, and administered in a dosing volume of 0.08 mg/mouse. SB-269970 (Sigma), 5HTR7 antagonist, and methysergide (Sigma), a 5HTR1, 2 and 7 antagonist, were dissolved in PBS and administered in a dosing volume of 0.6 and 0.1 mg/mouse, respectively. All antagonists were i.p. injected at 30 min before the injection of 1 mg 5-HT. After 120 min, samples were collected from skeletal muscle.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.